BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37599238)

  • 1. [Efficacy of non-surgical comprehensive treatment for locally advanced hypopharyngeal carcinoma with cervical esophagus invasion].
    Geng ZY; Chen NX; You W; Liu K; Gu X; Wei J; Ma L; Zhang XX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Aug; 58(8):773-780. PubMed ID: 37599238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retrospective analysis on 77 cases of T4b hypopharyngeal carcinoma treated by non-surgical treatments].
    Gu X; Liu K; Gou HC; Chen NX; Zhang XX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jan; 57(1):22-28. PubMed ID: 35090205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
    Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of combined radiotherapy with EGFR inhibitors and chemotherapy for laryngeal organ preservation in patients with locally advanced hypopharyngeal carcinomas.
    Zhang X; Wang J; Wu W; Liu M; Zhao F; Du L; Huang D; Yang S; Ma L
    Curr Cancer Drug Targets; 2014; 14(6):589-98. PubMed ID: 25039274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-surgical combined modality treatments for laryngeal organ preservation in advanced hypopharyngeal carcinoma].
    Zhang X; Wang J; Wu W; Ma L; Liu M; Zhao F; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):558-63. PubMed ID: 25257270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
    Li ZD; Lu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
    Xu W; Lyu Z; Yang Z; Zou J; Cao H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A single-arm prospective study on induction chemotherapy and subsequent comprehensive therapy for advanced hypopharyngeal squamous cell carcinoma: report of 260 cases in a single center].
    Yang YF; Wang R; Fang JG; Zhong Q; Huang ZG; Chen XH; Zhang SR; Gao JM; Li SL; Li PD; Hou LZ; Chen XJ; Ma HZ; Feng L; Zhang Y; He SZ; Lian M; Liu SZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1143-1153. PubMed ID: 33342130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical characteristics of 97 hypopharyngeal carcinoma cases].
    Lian X; Ji W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 29(6):542-6. PubMed ID: 26211163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survival outcomes and prognostic factors of patients with salvage surgery for hypopharyngeal carcinoma after radiotherapy].
    Huang Q; Wu ZH; Zhou L; You QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Feb; 57(2):191-196. PubMed ID: 35196763
    [No Abstract]   [Full Text] [Related]  

  • 13. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
    Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
    Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of surgical comprehensive therapy for 456 cases of hypopharyngeal carcinoma].
    Lyu ZH; Xu W; Ma JK; Feng SH; Jing PH; Liu XL; Zhou C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Jun; 58(6):558-564. PubMed ID: 37339895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gastric pull-up reconstruction after pharyngoesphagectomy for advanced hypopharyngeal or cervical esophageal squamous cell carcinoma].
    An CM; Wang SX; Lyu F; Liu SY; Xu ZG; Tang PZ; Gao SG; Yi JL; Li ZJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Oct; 51(10):740-745. PubMed ID: 27765102
    [No Abstract]   [Full Text] [Related]  

  • 17. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a treatment in patients with locoregionally advanced nasopharyngeal carcinoma (LANC) involving carotid artery invasion.
    Liu K; Wang Y; Ma L; Yang S; Zhang X
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5791-5799. PubMed ID: 35918541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk factors for recurrence and survival analysis in locally advanced T4a papillary thyroid carcinoma after R0 resection].
    Chen JM; Fang JG; Zhong YS; Lin LZ; Hou HZ; Ma L; Feng SZ; He Q; Shi M; Lian R; Wang XX; Shen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1044-1051. PubMed ID: 36177557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.